subject: Aarkstore Enterprise---f. Hoffmann-la Roche Ltd. (rog) - Financial And Strategic Analysis Review [print this page] F. Hoffmann-La Roche Ltd. (Roche), a holding company, is one of the leading research-based healthcare groups in the world with a wide range of innovative medical solutions. The company discovers, develops and offers innovative diagnostics and therapeutic products and services. The products and services of Roche are designed to address the prevention, diagnosis and treatment of diseases, improving the well-being and quality of life of patients. Its operations are concentrated in North America, Latin America, Europe and Japan. The company is headquartered in Basel, Switzerland.
F. Hoffmann-La Roche Ltd. Key Recent Developments
Apr 28, 2010: Roche Announces Joint Initiative To Train Healthcare Workers In Africas Fight Against Cancer
Apr 19, 2010: Roche Q1 Sales Up 6%
Apr 15, 2010: Roche Updates On ImmunoGen Trastuzumab-DM1 Regulatory Plans
Mar 22, 2010: Roche Receives Positive Opinion From CHMP For Use Of Tarceva
Mar 08, 2010: Roche, Biogen Idec To Terminate Ocrelizumab Treatment
This comprehensive SWOT analysis of F. Hoffmann-La Roche Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
